Selected article for: "antiviral activity and SARS DRV antiviral activity"

Author: Sandra De Meyer; Denisa Bojkova; Jindrich Cinati; Ellen Van Damme; Christophe Buyck; Marnix Van Loock; Brian Woodfall; Sandra Ciesek
Title: Lack of Antiviral Activity of Darunavir against SARS-CoV-2
  • Document date: 2020_4_8
  • ID: 679qfp2s_32
    Snippet: Several publications describe in silico docking experiments on the main coronavirus protease that specifically focus on or include DRV (17) (18) (19) (20) (21) . Although these studies suggest DRV as a candidate for further investigation, such promising docking results could not be reproduced in our in silico docking studies. Such discrepancies can often result from in silico docking, which is primarily a useful approach for identifying subsets o.....
    Document: Several publications describe in silico docking experiments on the main coronavirus protease that specifically focus on or include DRV (17) (18) (19) (20) (21) . Although these studies suggest DRV as a candidate for further investigation, such promising docking results could not be reproduced in our in silico docking studies. Such discrepancies can often result from in silico docking, which is primarily a useful approach for identifying subsets of molecules for in vitro activity testing. No in vitro antiviral activity of DRV against SARS-CoV-2 was found in the experiments reported here. All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • activity testing and vitro activity testing: 1, 2, 3, 4, 5, 6
    • antiviral activity and coronavirus protease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • antiviral activity and docking experiment: 1
    • antiviral activity and docking result: 1
    • antiviral activity and docking study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • antiviral activity and DRV antiviral activity: 1, 2, 3, 4
    • antiviral activity and investigation candidate: 1, 2, 3
    • antiviral activity and report experiment: 1
    • antiviral activity and SARS vitro DRV antiviral activity: 1, 2, 3
    • antiviral activity and silico docking: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • antiviral activity and silico docking study: 1, 2, 3
    • antiviral activity and vitro activity testing: 1
    • antiviral activity and vitro DRV antiviral activity: 1, 2
    • coronavirus protease and docking result: 1, 2, 3
    • coronavirus protease and docking study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • coronavirus protease and silico docking: 1, 2, 3, 4, 5, 6
    • coronavirus protease and silico docking study: 1, 2
    • docking experiment and silico docking: 1
    • docking experiment and silico docking experiment: 1